VETERINARY DRUGS COMPOUNDING MARKET ANALYSIS

Veterinary Drugs Compounding Market, By Drug Class (CNS Agents, Anti-infective Agents, Hormones and Substitutes, Anti-inflammatory Agents, Others), By Animal Type (Companion Animals and Livestock Animals), By Formulation (Oral, Injectable, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

In April 2022, The USFDA's Center for Veterinary Medicine released Final Guidance for Industry No. 256 on compounding animal drugs from bulk substances. It outlines when enforcement actions won't be taken, such as for specific prescriptions for non-food-producing animals or sedatives for free-ranging wildlife. The FDA encourages reporting adverse events and emphasizes compliance with state regulations.
In August 2022, Vimian Group, a leading provider of digital solutions, made a strategic move to enhance its services for veterinary clinics in Germany by acquiring Heiland GmbH, a prominent online ordering platform. This acquisition marks a pivotal moment in Vimian Group's efforts to digitize its wide-ranging service offerings for veterinary hospitals.

Veterinary Drugs Compounding Market Report Snapshots